Champlain Investment Partners, LLC Atri Cure, Inc. Transaction History
Champlain Investment Partners, LLC
- $15.1 Billion
- Q4 2024
A detailed history of Champlain Investment Partners, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Champlain Investment Partners, LLC holds 2,528,614 shares of ATRC stock, worth $99 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
2,528,614
Previous 2,790,758
9.39%
Holding current value
$99 Million
Previous $78.3 Million
1.25%
% of portfolio
0.51%
Previous 0.5%
Shares
22 transactions
Others Institutions Holding ATRC
# of Institutions
229Shares Held
47.1MCall Options Held
25.8KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.65MShares$182 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$181 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.84MShares$150 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.92MShares$114 Million1.54% of portfolio
-
Macquarie Group LTD Australia, C32.38MShares$93 Million0.08% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.82B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...